Ayala Pharmaceuticals Inc (ADXS)

[huskercatman123]

Hi Ignatius, it only makes sense to me that AMGEN would be the likely candidate for buying Advaxis. Infectious disease is also another huge potential market; especially with bacteria mutations, antibiotic resistant bacteria and the potential threat for a biological weapon. Here is a list of items that I have sent to Avaxis IR over the past two months:

https://www.fbo.gov/index?s=opportunity&mode=form&id=e8924ed4b2e33d904c135686f4372b61&tab=core&tabmode=list&=

https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-17-001.html

https://grants.nih.gov/grants/guide/notice-files/NOT-CA-17-045.html

And also this:

NIAID intends to award $42.7 million over seven years to the CoFAR so it may continue evaluating new approaches to treat food allergy.

NIAID Designates $42.7 Million for Food Allergy Research Consortium
Shelled peanuts in bowl

NIAID intends to award $42.7 million over seven years to the Consortium of Food Allergy Research (CoFAR) so it may continue evaluating new approaches to treat food allergy. CoFAR scientists are pursuing a technique called immunotherapy, which involves exposing the immune system to an allergen in a controlled way to eventually reduce immediate allergic symptoms and ultimately bring about long-term relief.